Hans Wigzell - Aug 4, 2023 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Hans Wigzell
Stock symbol
SRPT
Transactions as of
Aug 4, 2023
Transactions value $
-$1,165,350
Form type
4
Date filed
8/8/2023, 08:00 PM
Previous filing
Mar 8, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise $435K +15K +71.45% $29.03 36K Aug 4, 2023 Direct
transaction SRPT Common Stock Sale -$1.6M -15K -41.67% $106.72 21K Aug 4, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Stock Option (right to buy) Options Exercise $0 -15K -100% $0.00* 0 Aug 4, 2023 Common Stock 15K $29.03 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.42 to $107.04 per share. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.